Jan 12, 2026 Press Releases
PDF Version Not intended for UK Media Bayer bolsters development portfolio by acquisition of two investigational imaging agents (AT-01 and AT-05) from Attralus, Inc. to advance diagnosis for cardiac amyloidosis PET tracer AT-01 in Phase III and SPECT tracer AT-05 in...